))
Biopharma Perspective on Early Venture Investing and R&D
Manage episode 154229730 series 1116730
Contenu fourni par Columbia Tech Ventures and Columbia Technology Ventures. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Columbia Tech Ventures and Columbia Technology Ventures ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Presenting a panel discussion with Marian Nakada (Johnson & Johnson Innovation – JJDC), Bob Silverman (Roche) and Steven Weinstein (Novartis Ventures), moderated by CTV’s executive director Orin Herskowitz. The conversation touches on the various ways Big Pharma & Biotech are using venture capital investing, regional innovation centers, joint ventures, university research sponsorship, and IP licensing to source their next blockbuster products (as well as generate equity returns). The panelists share their perspectives on venture capital investing strategies in biopharma, how to pitch strategic investors, the surge in biotech IPOs, hot research areas within biopharma, and best practices for establishing R&D partnerships between industry and academia.
…
continue reading
15 episodes
Partager
